Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

14.21
-0.1600-1.11%
Post-market: 14.400.1900+1.34%19:58 EDT
Volume:1.55M
Turnover:22.04M
Market Cap:1.69B
PE:-13.66
High:14.85
Open:14.75
Low:14.08
Close:14.37
Loading ...
Jul 25, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Jul 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 10, 2024

Major Issues Report

Form 8-K - Current report
Mar 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities